First‐In‐Human, Single Ascending Dose and Food‐Effect Study in Healthy Volunteers of SUL‐238, a Novel Orally Administered Mitochondria‐Directed Drug Candidate
In this Phase 1, first-in-human, healthy volunteer study, 50-2000 mg single oral doses of SUL-238 were safe and well-tolerated, while demonstrating a favourable PK profile, and a high CSF penetration.
Authors
- Nadir Ulu (ORCID: https://orcid.org/0000-0002-2681-8615)
- Murat Emre
- Adrianus C. van der Graaf
- Sedat Altuǧ
- Serhat Kozlu
- Ahmet İnal
- Daniël Henri Swart
- Mustafa Mümtaz Mazıcıoğlu
- Robert Henk Henning
- Zafer Sezer
- Guido Krenning
Institutions
- University Medical Center Groningen (NL)
- Istanbul Bilim University (TR)
- Ankara Sosyal Bilimler Üniversitesi (TR)
- Kayseri Eğitim ve Araştırma Hastanesi (TR)
- Istanbul University (TR)
- Erciyes University (TR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_100985
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00